While recent CDC guidance threatens to shrink the market for a new class of immunizations, GSK continues to build the case ...

As part of the agreement, GSK, Sanofi, and CSL will produce extra bulk vaccine components tailored to the circulating strains of avian influenza. Also Read: Medicare Drug Price Negotiation Program ...

GSK and iTeos anti-TIGIT antibody belrestotug showed efficacy in a phase 2 trial in PD-L1-positive non-small cell lung cancer (NSCLC), providing some much-needed positive news for the beleaguered ...

An antibody-drug conjugate (ADC) that GSK licensed from China's Hansoh Pharma in a $1.7 billion deal last year has been given breakthrough status by the FDA. The coveted designation for GSK5764227 ...

Teva Pharmaceutical Industries Ltd. ADR-0.76% $19.75B ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.As of 7th Oct,2024, the GSK Pharma Share Price on NSE closed at Rs. 2706.2, featuring amongst the most traded securities on ...

After hours: 4 October at 19:59 GMT-4 ...

As of , had a $0.0 market capitalization, putting it in the percentile of companies in the industry. does not have a meaningful P/E due to negative earnings over the last 12 trailing months. ’s ...

Lijun Hu; Mimi Zhou; Andrew Young; Weiwei Zhao; Zhimin Yan ...